@inproceedings{inproceedings, title  = {{Sustained long-term dupilumab efficacy in adult patients with moderate-to-severe atopic dermatitis transitioning from weekly dosing to every other week: Results from an open-label extension trial}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Cork MJ and Beck LA and Deleuran M and Hong HC-H and Adam DN and Hussain I and Zhang H and Shabbir A and Rodriguez Marco A and Levit NA}},

 volume = {{52}},

 journal = {{CLINICAL AND EXPERIMENTAL ALLERGY}},

 issue = {{8}},

 pages = {{1014-1014}},

 note = {{Accessed on 2024/12/22}}}